Finding the sweet spot: shorter blood thinner course after brain stent may be safer
NCT ID NCT05257824
Summary
This study aimed to find the safest length of time for patients to take two blood-thinning medications after receiving a stent to treat an unruptured brain aneurysm. Researchers compared taking the medications for 6 months versus 12 months to see which duration better prevented strokes caused by clots while also avoiding serious bleeding risks. The goal was to determine the optimal treatment plan to control the aneurysm with the fewest complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSM CEREBRAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Chungnam National University Sejong Hospital
Sejong, Chungcheongnam-do, 30099, South Korea
-
Keimyung University Dongsan Medical Center
Daegu, 42601, South Korea
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, 50612, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Soonchunhyang University Seoul Hospital
Seoul, 04401, South Korea
-
Uijeongbu St. Mary's Hospital
Uijeongbu-si, 11765, South Korea
-
Yonsei University Gangnam Severance Hospital
Seoul, 06273, South Korea
Conditions
Explore the condition pages connected to this study.